178 related articles for article (PubMed ID: 28379068)
21. Impact of pharmacy services on cystic fibrosis medication adherence.
Zobell JT; Schwab E; Collingridge DS; Ball C; Nohavec R; Asfour F
Pediatr Pulmonol; 2017 Aug; 52(8):1006-1012. PubMed ID: 28608652
[TBL] [Abstract][Full Text] [Related]
22. Specialty pharmacy for hematologic malignancies.
Fajardo S; Zook F; Dotson E
Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
[TBL] [Abstract][Full Text] [Related]
23. Specialty pharmacy services for patients receiving oral medications for solid tumors.
Stein J; Mann J
Am J Health Syst Pharm; 2016 Jun; 73(11):775-96. PubMed ID: 27126828
[TBL] [Abstract][Full Text] [Related]
24. Greater refill adherence to adalimumab therapy for patients using specialty versus retail pharmacies.
Liu Y; Yang M; Chao J; Mulani PM
Adv Ther; 2010 Aug; 27(8):523-32. PubMed ID: 20652656
[TBL] [Abstract][Full Text] [Related]
25. Promoting Safe Use of Medications: Providing Medication Education to Seniors Receiving Meals on Wheels.
Ward KE; Cohen LB
Consult Pharm; 2015 Oct; 30(10):616-22. PubMed ID: 26450144
[TBL] [Abstract][Full Text] [Related]
26. Impact of pharmacy channel on adherence to oral oncolytics.
Stokes M; Reyes C; Xia Y; Alas V; Goertz HP; Boulanger L
BMC Health Serv Res; 2017 Jun; 17(1):414. PubMed ID: 28629454
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center.
Solomon JM; Ajewole VB; Schneider AM; Sharma M; Bernicker EH
J Oncol Pharm Pract; 2019 Oct; 25(7):1564-1569. PubMed ID: 30170514
[TBL] [Abstract][Full Text] [Related]
28. Measuring pharmacy performance in the area of medication adherence: addressing the issue of risk adjustment.
Dharmarajan S; Bentley JP; Banahan Iii BF; West-Strum DS
J Manag Care Spec Pharm; 2014 Oct; 20(10):1057-68. PubMed ID: 25278328
[TBL] [Abstract][Full Text] [Related]
29. Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist.
Banks AM; Peter ME; Holder GM; Jolly JA; Markley BM; Zuckerman SL; Choi L; Nwosu S; Zuckerman AD
J Pharm Pract; 2020 Oct; 33(5):605-611. PubMed ID: 30700202
[TBL] [Abstract][Full Text] [Related]
30. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
[TBL] [Abstract][Full Text] [Related]
31. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
32. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
[TBL] [Abstract][Full Text] [Related]
33. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
34. Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions.
Khandelwal N; Duncan I; Ahmed T; Rubinstein E; Pegus C
J Natl Compr Canc Netw; 2012 May; 10(5):618-25. PubMed ID: 22570292
[TBL] [Abstract][Full Text] [Related]
35. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
36. Medication synchronization service for patients with multiple myeloma within a health system-based specialty pharmacy.
Costello F; Kumor L; Stubbings J
Am J Health Syst Pharm; 2020 Dec; 77(24):2042-2044. PubMed ID: 33091100
[No Abstract] [Full Text] [Related]
37. High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach.
Shah NB; Mitchell RE; Proctor ST; Choi L; DeClercq J; Jolly JA; Hemnes AR; Zuckerman AD
PLoS One; 2019; 14(6):e0217798. PubMed ID: 31170217
[TBL] [Abstract][Full Text] [Related]
38. Pharmacy effect on adherence to antidiabetic medications.
Sharma KP; Taylor TN
Med Care; 2012 Aug; 50(8):685-91. PubMed ID: 22354211
[TBL] [Abstract][Full Text] [Related]
39. Pilot study evaluating feasibility and utility of pharmacist-driven oral antineoplastic agent monitoring program.
Allen SM; Cervantez SR; Frei BL; Koeller JM
J Oncol Pharm Pract; 2024 Mar; 30(2):263-269. PubMed ID: 37431251
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a Hepatitis C Patient Management Program at a University Specialty Pharmacy.
Zaepfel M; Cristofaro L; Trawinski A; McCarthy K; Rightmier E; Khadem T
Ann Pharmacother; 2017 Apr; 51(4):307-314. PubMed ID: 28228059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
